Entheon Biomedical Corp. (CSE: ENBI)

Market Cap	2.39M
Revenue (ttm)	n/a
Net Income (ttm)	-307.69K
Shares Out	8.86M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	9,760
Open	0.300
Previous Close	0.270
Day's Range	0.300 - 0.300
52-Week Range	0.050 - 0.300
Beta	0.98
RSI	65.35
Earnings Date	Mar 21, 2025

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Timothy Ko
• Employees: 2
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: ENBI

Financial Performance

In 2023, Entheon Biomedical's revenue was 250,323, an increase of 31.97% compared to the previous year's 189,677. Losses were -300,001, -96.48% less than in 2022.